{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=RSV+Vaccine&page=2", "query": { "intervention": "RSV Vaccine", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=RSV+Vaccine&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T11:05:49.701Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01290419", "title": "Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSV-F Particle Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 150, "start_date": "2010-12", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2012-03-08", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01290419" }, { "nct_id": "NCT02873286", "title": "RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "MVA-BN-RSV", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Bavarian Nordic", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 420, "start_date": "2016-09", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2020-09-22", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 12, "location_summary": "Redding, California • San Diego, California • The Villages, Florida + 9 more", "locations": [ { "city": "Redding", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "The Villages", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Stockbridge", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02873286" }, { "nct_id": "NCT05170399", "title": "Vaccine Responses in Patients With B Cell Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "AREXVY, ABRYSVO", "type": "DRUG" }, { "name": "PREVNAR 20", "type": "DRUG" }, { "name": "PNEUMOVAX 23", "type": "BIOLOGICAL" }, { "name": "Heplisav -B", "type": "BIOLOGICAL" }, { "name": "PREVNAR 13", "type": "BIOLOGICAL" }, { "name": "Shingrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 350, "start_date": "2022-09-14", "completion_date": "2036-11-15", "has_results": false, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05170399" }, { "nct_id": "NCT02237209", "title": "Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSV LID ΔM2-2 Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "6 Months to 24 Months" }, "enrollment_count": 29, "start_date": "2014-09", "completion_date": "2015-04", "has_results": false, "last_update_posted_date": "2015-10-08", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 7, "location_summary": "Alhambra, California • La Jolla, California • Aurora, Colorado + 3 more", "locations": [ { "city": "Alhambra", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02237209" }, { "nct_id": "NCT01709019", "title": "RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Respiratory Syncytial Virus (RSV)" ], "interventions": [ { "name": "Low dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)", "type": "BIOLOGICAL" }, { "name": "Low dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & day 28)", "type": "BIOLOGICAL" }, { "name": "High dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)", "type": "BIOLOGICAL" }, { "name": "High dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)", "type": "BIOLOGICAL" }, { "name": "Placebo (Day 0 & Day 28); Seasonal TIV (Day 0)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 220, "start_date": "2012-10", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2014-03-05", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 4, "location_summary": "Tucson, Arizona • Melbourne, Florida • Dallas, Texas + 1 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Dallas", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01709019" }, { "nct_id": "NCT05900154", "title": "A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "RESPIRATORY SYNCYTIAL VIRUS (RSV)" ], "interventions": [ { "name": "RSVpreF 120 µg", "type": "BIOLOGICAL" }, { "name": "RSVpreF 60 µg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 128, "start_date": "2023-06-22", "completion_date": "2024-02-29", "has_results": true, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Palo Alto, California • Rolling Hills Estates, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Sioux City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT05900154" }, { "nct_id": "NCT01968083", "title": "Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSV cps2 Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "6 Months to 24 Months" }, "enrollment_count": 51, "start_date": "2013-10-03", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2021-07-26", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 5, "location_summary": "La Jolla, California • Long Beach, California • Denver, Colorado + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01968083" }, { "nct_id": "NCT03572062", "title": "A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Tract Infection" ], "interventions": [ { "name": "Formulation A", "type": "BIOLOGICAL" }, { "name": "Formulation B", "type": "BIOLOGICAL" }, { "name": "Formulation C", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "65 Years to 85 Years" }, "enrollment_count": 317, "start_date": "2018-06-05", "completion_date": "2020-08-19", "has_results": true, "last_update_posted_date": "2021-08-26", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 4, "location_summary": "South Miami, Florida • Peoria, Illinois • Fremont, Nebraska + 1 more", "locations": [ { "city": "South Miami", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Fremont", "state": "Nebraska" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03572062" }, { "nct_id": "NCT04605159", "title": "A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSV MAT", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "18 Years to 49 Years · Female only" }, "enrollment_count": 11194, "start_date": "2020-11-20", "completion_date": "2023-06-14", "has_results": true, "last_update_posted_date": "2025-02-20", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04605159" }, { "nct_id": "NCT02830932", "title": "Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Respiratory Syncytial Virus (RSV)" ], "interventions": [ { "name": "VXA-RSV-f Tablets (high dose)", "type": "BIOLOGICAL" }, { "name": "VXA Placebo Tablets", "type": "OTHER" }, { "name": "VXA-RSV-f Tablets (low dose)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Vaxart", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 66, "start_date": "2016-06-22", "completion_date": "2017-09-20", "has_results": false, "last_update_posted_date": "2018-08-16", "last_synced_at": "2026-09-27T11:05:49.701Z", "location_count": 1, "location_summary": "Melbourne, Florida", "locations": [ { "city": "Melbourne", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02830932" } ] }